Decentralized manufacturing SIG

This working group convenes experts and stakeholders to explore the future of decentralized manufacturing in cell therapy. Participants will engage in breakout discussions addressing regulatory frameworks, technology readiness, quality assurance, and strategies to expand patient access. This interactive session will highlight the emerging models and collaborative strategies that will improve scalability, operational resilience, and equitable distribution of cell therapies globally, fostering a more sustainable and accessible cell therapy ecosystem.